European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Retailers of Medical Goods Share by Country (Million Euros)

The European healthcare expenditure on pharmaceuticals and medical non-durable goods by retailers shows significant variations across countries. In 2023, Germany led with the highest expenditure, reflecting robust growth of 4.94% year-on-year. France, with modest 0.59% growth, and Italy, experiencing a minor decline of 0.31%, illustrate stable but varied trends. Spain and the Netherlands posted notable increases at 4.19% and 4.46%, respectively. Smaller markets like Cyprus and Malta exhibited vigorous growth rates of 15.73% and 10.64%. The compound annual growth rate over five years highlights divergence in markets, with Eastern Europe generally showing higher growth rates compared to Western Europe.

Future trends to watch include:

• Continued growth in Central and Eastern European countries could shift market dynamics.
• Digital health adoption and innovations in pharmaceutical distribution may impact retail sales.
• Policy changes and economic conditions could influence healthcare spending priorities.